RIT1 oncoproteins escape LZTR1-mediated proteolysis

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• RIT1 oncoproteins are implicated in Noonan syndrome and cancer.
• Mutations in RIT1 occur in a unique region, distinct from canonical Ras GTPase mutation hotspots.
• The precise pathogenic mechanism of RIT1 mutations remains incompletely understood.

Purpose of the Study:

• To investigate the organismal effects of RIT1 mutations using a mouse model.
• To identify RIT1 interactors involved in its regulation.
• To elucidate the molecular mechanism underlying RIT1-associated pathologies.

Main Methods:

• Generation of an isogenic germline knock-in mouse model for RIT1 mutation.
• Mass spectrometry to identify RIT1-interacting proteins.
• Analysis of RIT1 protein levels and downstream signaling pathways.

Main Results:

• The mouse model exhibited a phenotype consistent with Noonan syndrome.
• Leucine zipper-like transcription regulator 1 (LZTR1) was identified as a RIT1 interactor and adaptor for protein degradation.
• Pathogenic mutations in RIT1 or LZTR1 led to impaired RIT1 degradation and subsequent accumulation.
• Accumulated RIT1 resulted in dysregulated growth factor signaling.

Conclusions:

• RIT1 accumulation due to impaired protein degradation is a key pathogenic mechanism in Noonan syndrome and cancer.
• LZTR1 plays a critical role in regulating RIT1 stability.
• Targeting RIT1 degradation pathways may offer therapeutic strategies for RIT1-related disorders.